Related Experiment Videos
[Colchicine intoxication in four elderly patients: how to prevent it?]
M-L Le Bellec1, B de la Gastine, B Mosquet
1Centre régional de pharmacovigilance, CHU Côte-de-Nacre, avenue de la Côte-de-Nacre, BP 95182, 14033 Caen cedex 9, France.
Summary
Colchicine is a common gout treatment in France, but elderly patients are at risk of intoxication. Specific guidelines are needed to ensure safe colchicine use in this population.
Area of Science:
- Pharmacology
- Geriatrics
- Clinical Toxicology
Background:
- Colchicine is frequently prescribed for gout management in France.
- Its use is prevalent despite the availability of other anti-inflammatory agents.
Observation:
- A case series of four elderly patients (72-83 years) with colchicine intoxication was reported.
- Identified risk factors included renal failure, high initial dosage, and lack of laboratory monitoring.
Findings:
- Elderly patients are susceptible to colchicine toxicity.
- Risk factors for intoxication are associated with renal impairment, dosing, and inadequate monitoring.
Implications:
- Development of specific clinical guidelines for colchicine prescription in the elderly is warranted.
- Enhanced pharmacovigilance and patient monitoring are crucial for preventing adverse events.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Prevention of Further Absorption of Poison
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...